Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib

Clinical trial NCT00820417 · COMPLETED

Trial details

NCT number: NCT00820417
Sponsor: Harrison Clinical Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Head and Neck Cancer Non Small Cell Lung Cancer (NSCLC)

Start date: 2004-06-01
Primary completion: 2007-09-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.